» Articles » PMID: 35528720

Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital - A Tertiary Referral Center

Abstract

Purpose: This study aimed to investigate the clinical characteristics, glycemic control, and microvascular complications compared between young-onset type 1 (T1DM) and type 2 diabetes (T2DM) patients at Siriraj Hospital.

Patients And Methods: We collected demographic, clinical, glycemic control, and microvascular complication data of young-onset (onset <30 years of age) T1DM and T2DM patients at our center using February 2019-December 2020 data from the Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN).

Results: Of 396 patients, 76% had T1DM and 24% had T2DM. At diagnosis, T1DM were significantly younger (9.7±5.4 vs 16.9±6.4 years, <0.001), had a lower body mass index (17.2±4.1 vs 30.8±7.9 kg/m, <0.001), higher prevalence of diabetic ketoacidosis (DKA) (66.1% vs 13.7%, <0.001), and higher HbA level (12.8±2.6% vs 10.9±3.1%, =0.002) compared to T2DM. Regarding glycemic control, the mean HbA at registry enrollment did not differ between groups (T1DM 8.3±1.8% vs T2DM 8.1±2.2%, =0.303), but T1DM achieved HbA <7% significantly less than T2DM (19.3% vs 47.8%, <0.001). T1DM showed deterioration of glycemic control during 10-20 years of age, and gradually improved during 20-30 years of age, whereas patients with T2DM showed progressive worsening of glycemic control over time. Concerning microvascular complications, the prevalence of diabetic retinopathy (10.6% vs 9%, =0.92) and diabetic neuropathy (3.4% vs 5.5%, =0.514) between T1DM and T2DM was not significantly different. However, T2DM had a significantly higher prevalence of diabetic nephropathy (T1DM 10.1% vs T2DM 40.2%, <0.001) that developed within a significantly shorter duration of diabetes (T1DM 11.0±6.8 vs T2DM 4.3±5.1 years, <0.001) compared to T1DM.

Conclusion: T1DM had a significantly high prevalence of DKA at presentation, and most T1DM did not achieve the glycemic target, especially during adolescence. T2DM had a significantly higher prevalence of diabetic nephropathy that developed within a shorter duration of diabetes compared to T1DM.

Citing Articles

Comparison of clinical characteristics and treatment outcomes between initially diagnosed type 1 and type 2 diabetes mellitus patients presenting with diabetic ketoacidosis.

Mookpaksacharoen O, Choksakunwong S, Lertwattanarak R BMC Endocr Disord. 2024; 24(1):114.

PMID: 39010018 PMC: 11247844. DOI: 10.1186/s12902-024-01649-7.


Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.

Cioana M, Deng J, Nadarajah A, Hou M, Qiu Y, Chen S JAMA Netw Open. 2023; 6(3):e231887.

PMID: 36930156 PMC: 10024209. DOI: 10.1001/jamanetworkopen.2023.1887.

References
1.
Lascar N, Brown J, Pattison H, Barnett A, Bailey C, Bellary S . Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2017; 6(1):69-80. DOI: 10.1016/S2213-8587(17)30186-9. View

2.
Gerstl E, Rabl W, Rosenbauer J, Grobe H, Hofer S, Krause U . Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr. 2007; 167(4):447-53. DOI: 10.1007/s00431-007-0586-9. View

3.
Cameron F, Garvey K, Hood K, Acerini C, Codner E . ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes in adolescence. Pediatr Diabetes. 2018; 19 Suppl 27:250-261. DOI: 10.1111/pedi.12702. View

4.
. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013; 36(6):1735-41. PMC: 3661847. DOI: 10.2337/dc12-2420. View

5.
Khandelwal S, Sengar G, Sharma M, Choudhary S, Nagaraj N . Psychosocial Illness in Children with Type 1 Diabetes Mellitus: Prevalence, Pattern and Risk Factors. J Clin Diagn Res. 2016; 10(9):SC05-SC08. PMC: 5072039. DOI: 10.7860/JCDR/2016/21666.8549. View